Anti-viral drug should not be first choice in treating COVID-19

3 December 2022 - The most widely prescribed anti-viral drug in Australia, molnupiravir, should no longer be routinely given for ...

Read more →

Hopes $55k breast cancer drug Keytruda will get PBS listing

3 December 2022 - Women with triple negative breast cancer have been given new hope that immunotherapy drug Keytruda will ...

Read more →

Agenda for the December 2022 PBAC intracycle meeting

2 December 2022 - The agenda for the December 2022 PBAC intracycle meeting is now available. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 December 2022

1 December 2022 - The December 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

External consultation on the draft revised post-market review framework (deadline extension)

29 November 2022 - The Department of Health and Aged Care has received a request to extend the consultation period on ...

Read more →

Type 2 diabetes drug shortage: Victoria’s Ozempic, Trulicity supplies limited until March

28 November 2022 - Type 2 diabetes sufferers are spending hours driving around the suburbs begging pharmacists for a drug that’s ...

Read more →

Cheaper medicines for high cholesterol and chronic heart failure

28 November 2022 - From 1 December 2022, Australians with high cholesterol, chronic heart failure, and a potentially life-threatening blood cell ...

Read more →

Cost of life-saving heart disease drugs slashed, saving patients thousands

27 November 2022 - Life-saving medicines that tackle Australia's biggest killer are about to be added to the Pharmaceutical Benefits ...

Read more →

Outcome in relation to discussion of COVID-19 oral treatments – November 2022 PBAC meeting

24 November 2022 - A PBAC outcome in relation to discussion of COVID-19 oral treatments at the November 2022 meeting has ...

Read more →

Agenda for the March 2023 PBAC meeting

23 November 2022 - The agenda for the March 2023 PBAC meeting is now available. ...

Read more →

Medicines industry calls for discount rate reduction now

18 November 2022 - Medicines Australia welcomes the recommendation to lower the discount rate for medicines and vaccines but questions ...

Read more →

PBAC Public Summary Document (November 2022)

18 November 2022 - The Public Summary Documents for the Review of the base-case discount rate in the PBAC Guidelines from ...

Read more →

New COVID-19 vaccines for eligible Australians

15 November 2022 - The Australian Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation (ATAGI) on ...

Read more →

NSW pharmacists to prescribe the pill, antibiotics in health shake-up

13 November 2022 - Pharmacists will be able to prescribe a range of meds and repeat scripts under a NSW government ...

Read more →

Public Summary Documents – September 2022 PBAC meeting

11 November 2022 - The Public Summary Document for tixagevimab and cilgavimab (Evusheld) from the September 2022 PBAC intracycle meeting is ...

Read more →